Ontology highlight
ABSTRACT: Background
In autism spectrum disorder (ASD), the human plasma metabolome is altered but the causal relationship between the levels of metabolites and ASD is unclear. We aimed to assess bidirectional causal associations between plasma metabolites and ASD.Methods
We investigated potential causal associations between the genetic variation contributing to the levels of metabolites and ASD via Mendelian randomization (MR) analyses. Genome-wide association study (GWAS) summary datasets were used in the study, including ASD (n = 46,350) and 871 plasma metabolite (n = 8299) datasets. We used druggability analysis to prioritize metabolites with therapeutic potential.Results
Our MR analysis identified 32 plasma metabolites whose levels were protective against the risk of ASD
SUBMITTER: Shi S
PROVIDER: S-EPMC12781214 | biostudies-literature | 2025 Dec
REPOSITORIES: biostudies-literature